AltaThera Pharmaceuticals, a pharmaceutical company focused on pioneering therapies to address critical gaps in cardiac care, is excited to be participating in the upcoming Florida Society Of Health-System Pharmacists (FSHP) Annual Meeting 2026 meeting hosted in Orlando, FL from August 7 – August 9, 2026.
Attendees are welcome to stop by the AltaThera booth to learn more about our company and Sotalol IV (sotalol hydrochloride injection). Schedule a meeting with us in advance by contacting us at https://www.altathera.com/contact.
Learn more about the event here: https://fshp.org/annual-meeting/
BOXED WARNING: Life-Threatening Proarrhythmia. Please see full prescribing information including boxed warning, contraindications, and dosing, at www.altathera.com/sotalol-iv-pi/.